Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPK
- Authors
- Kar, Siddhartha; Wang, Meifang; Ham, Seung Wook; Carr, Brian I.
- Issue Date
- Nov-2006
- Publisher
- PERGAMON-ELSEVIER SCIENCE LTD
- Keywords
- liver cancer; protein phosphatase; K-vitamin derivative; cell cycle inhibition; Cdc25; MAPK
- Citation
- BIOCHEMICAL PHARMACOLOGY, v.72, no.10, pp 1217 - 1227
- Pages
- 11
- Journal Title
- BIOCHEMICAL PHARMACOLOGY
- Volume
- 72
- Number
- 10
- Start Page
- 1217
- End Page
- 1227
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/24240
- DOI
- 10.1016/j.bcp.2006.07.024
- ISSN
- 0006-2952
1873-2968
- Abstract
- We previously synthesized several K-vitamin derivatives, which are potent growth inhibitors of human tumor cells, including Hep3B human hepatoma cells. Among these, Cpd 5 was the most potent. However, being a quinone derivative, Cpd 5 has the potential for generating toxic reactive oxygen species (ROS). We therefore synthesized a fluorinated derivative of Cpd 5, F-Cpd 5. The calculated reduction potential of F-Cpd 5 was much higher than that for Cpd S and it was not predicted to generate ROS. This was supported by our observation that F-Cpd 5 generated significantly lower ROS than Cpd 5. F-Cpd 5 was three times more potent than Cpd 5 in inhibiting Hep3B cell growth. Interestingly, under identical culture conditions, F-Cpd 5 inhibited mitogen-induced DNA synthesis in normal rat hepatocytes 12-fold less potently than Hep3B cells. F-Cpd 5 was found to induce caspase-3 cleavage and nuclear DNA laddering, evidences for apoptosis. It preferentially inhibited the activities of the cell cycle controlling phosphatases Cdc25A and Cdc25B, by binding to their catalytic cysteines. Consequently, inhibitory tyrosine phosphorylation of the Cdc25 substrate kinases Cdk2 and Cdk4 were induced. F-Cpd 5 also induced phosphorylation of the MAPK proteins ERK1/2, JNK1/2 and p38 in Hep3B cells and the MAPK inhibitors (U0126, JNKI-II, and SB 203580) antagonized its growth inhibition. F-Cpd 5 inhibited the action of cytosolic ERK phosphatase activity, which likely caused the ERK phosphorylation. F-Cpd 5 thus differentially inhibited growth of normal and tumor cells by preferentially inhibiting the actions of Cdc25A and Cdc25B phosphatases and inducing MAPK phosphorylation. (c) 2006 Elsevier Inc. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Natural Sciences > Department of Chemistry > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/24240)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.